The comparative efficacy and safety of the angiotensin receptor blockers in the management of hypertension and other cardiovascular diseases
All national guidelines for the management of hypertension recommend angiotensin
receptor blockers (ARBs) as an initial or add-on antihypertensive therapy. The eight …
receptor blockers (ARBs) as an initial or add-on antihypertensive therapy. The eight …
Peripheral edema associated with calcium channel blockers: incidence and withdrawal rate–a meta-analysis of randomized trials
Objective Peripheral edema is considered to be a common and annoying adverse effect of
calcium channel blockers (CCBs). It has been thought to occur secondary to arteriolar …
calcium channel blockers (CCBs). It has been thought to occur secondary to arteriolar …
Combination therapy in hypertension
AH Gradman, JN Basile, BL Carter, GL Bakris… - Journal of the American …, 2010 - Elsevier
The goal of antihypertensive therapy is to abolish the risks associated with blood pressure
(BP) elevation without adversely affecting quality of life. Drug selection is based on efficacy …
(BP) elevation without adversely affecting quality of life. Drug selection is based on efficacy …
Сахарный диабет и хроническая болезнь почек
МВ Шестакова, ИИ Дедов - 2009 - elibrary.ru
В книге представлены современные данные об эпидемиологии, патогенезе,
профилактике и лечении различных вариантов поражения почек при сахарном …
профилактике и лечении различных вариантов поражения почек при сахарном …
The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8 …
SG Chrysant, M Melino, S Karki, J Lee, R Heyrman - Clinical therapeutics, 2008 - Elsevier
Background: Hypertension guidelines recommend the use of 2 agents having
complementary mechanisms of action when> 1 agent is needed to achieve blood pressure …
complementary mechanisms of action when> 1 agent is needed to achieve blood pressure …
Triple antihypertensive therapy with amlodipine, valsartan, and hydrochlorothiazide: a randomized clinical trial
DA Calhoun, Y Lacourciere, YT Chiang, RD Glazer - Hypertension, 2009 - Am Heart Assoc
Many patients with hypertension require≥ 3 agents to achieve target blood pressure (BP).
The efficacy/safety of the dual combinations of valsartan (Val)/hydrochlorothiazide (HCTZ) …
The efficacy/safety of the dual combinations of valsartan (Val)/hydrochlorothiazide (HCTZ) …
Aliskiren and the calcium channel blocker amlodipine combination as an initial treatment strategy for hypertension control (ACCELERATE): a randomised, parallel …
MJ Brown, GT McInnes, CC Papst, J Zhang… - The Lancet, 2011 - thelancet.com
Background Short-term studies have suggested that the use of initial combination therapy for
the control of blood pressure improves early effectiveness. We tested whether a combination …
the control of blood pressure improves early effectiveness. We tested whether a combination …
Combination therapy in hypertension
AH Gradman, JN Basile, BL Carter… - The Journal of …, 2011 - Wiley Online Library
Editor's Note: The American Society of Hypertension is publishing a series of Position
Papers in their official journals throughout the 2008–2011 years. The following Position …
Papers in their official journals throughout the 2008–2011 years. The following Position …
Effect of renin-angiotensin system blockade on calcium channel blocker-associated peripheral edema
BACKGROUND: Peripheral edema is a common adverse effect of calcium channel blockers.
The addition of a renin-angiotensin system blocker, either an angiotensin-converting …
The addition of a renin-angiotensin system blocker, either an angiotensin-converting …
[PDF][PDF] 初始低剂量氨氯地平加替米沙坦或复方阿米洛利联合治疗对高血压患者血压控制率影响的阶段报告
王文, 马丽媛, 刘明波, 邓卿, 张宇清, 李卫, 朱鼎良… - 2009 - nccd.org.cn
初始低剂量氨氯地平加替米沙坦或复方阿米洛利联合治疗对高血压患者血压控制率影响的阶段报
Page 1 初始低剂量氨氯地平加替米沙坦或复方 阿米洛利联合治疗对高血压患者血压 控制率影响 …
Page 1 初始低剂量氨氯地平加替米沙坦或复方 阿米洛利联合治疗对高血压患者血压 控制率影响 …